China Hastens New Drug Development, Bayer Starts 20 New Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Bayer HealthCare China President Li Xilie, revealed April 28 that Bayer Schering Pharma started 20 new drug clinical trials in China last year
You may also be interested in...
Bayer Schering Forges Women's Health Research Partnership With Beijing's People's Liberation Army General Hospital
PERTH, Australia - Bayer Schering Pharma AG has forged a long-term strategic research partnership in the area of women's health with the People's Liberation Army General Hospital, known as 301 Hospital, in Beijing
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.